Stepan (NYSE: SCL) insider transactions
In the twelve months to 10 November 2026, executives and directors of Stepan reported no open-market sales and no open-market purchases, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 10 November 2026 | Barry Andrea Jean | SVP & Chro | Shares withheld for tax | −114 | $67.90 | 288 | Form 4 |
| 9 November 2026 | Barry Andrea Jean | SVP & Chro | Option exercise | +386 | $67.90 | 402 | Form 4 |
| 3 November 2026 | Stepan F Quinn JR | Director | Gift | −1,430 | — | 157,993 | Form 4 |
| 26 August 2026 | Lisle Shawn G | VP GC & Secretary | Option exercise | +1,154 | $62.35 | 1,180 | Form 4 |
| 26 August 2026 | Lisle Shawn G | VP GC & Secretary | Shares withheld for tax | −339 | $62.35 | 841 | Form 4 |
| 10 August 2026 | Velasquez Ruben Dario | SVP & Chief Financial Officer | Option exercise | +1,358 | $64.68 | 1,394 | Form 4 |
| 10 August 2026 | Velasquez Ruben Dario | SVP & Chief Financial Officer | Shares withheld for tax | −398 | $64.68 | 996 | Form 4 |
| 11 May 2026 | Weitkamp Robin Joseph | VP and GM Surfactants-INT | Option exercise | +90 | $52.58 | 90 | Form 4 |
| 11 May 2026 | Weitkamp Robin Joseph | VP and GM Surfactants-INT | Shares withheld for tax | −50 | $52.58 | 40 | Form 4 |
| 8 May 2026 | Dearth Randall S. | Director | Grant or award | +2,566 | $52.61 | 16,672 | Form 4 |
| 8 May 2026 | Burgess Lorinda | Director | Grant or award | +2,566 | $52.61 | 5,900 | Form 4 |
| 8 May 2026 | Delgado Joaquin | Director | Grant or award | +2,566 | $52.61 | 18,637 | Form 4 |
| 8 May 2026 | Lewis Susan | Director | Grant or award | +2,566 | $52.61 | 6,962 | Form 4 |
| 8 May 2026 | Reed Jan Stern | Director | Grant or award | +2,566 | $52.61 | 16,477 | Form 4 |
| 8 May 2026 | Stepan F Quinn JR | Director | Grant or award | +2,566 | $52.61 | 143,007 | Form 4 |
| 8 May 2026 | Painter Corning F. | Director | Grant or award | +2,566 | $52.61 | 4,999 | Form 4 |
| 1 May 2026 | Haire Robert Joseph | EVP, Supply Chain | Option exercise | +550 | $50.33 | 4,510 | Form 4 |
| 1 May 2026 | Haire Robert Joseph | EVP, Supply Chain | Shares withheld for tax | −162 | $50.33 | 3,960 | Form 4 |
| 4 March 2026 | Moriarty Sean Thomas | VP & GM Surfactants | Shares withheld for tax | −166 | $49.62 | 15,710 | Form 4 |
| 4 March 2026 | Moriarty Sean Thomas | VP & GM Surfactants | Option exercise | +571 | $49.62 | 15,876 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Stepan page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.